Physician profile
Debra Young
NPI 1336444645
$3,316.32
in general payments reported to CMS, 2019-2025
27 companies · $642 in 2025
The $642 reported for 2025 was more than what 80% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $303 · 2022: $618 · 2023: $1,182 · 2024: $572 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $294.30 | 2022-2023 | |
| Abbvie INC. | $293.82 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $289.18 | 2022-2025 | Wainua, Airsupra |
| Novo Nordisk INC | $205.30 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $160.99 | 2023 | Quviviq |
| Abiomed | $146.52 | 2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.44 | 2023-2024 | Lifevest |
| Sage Therapeutics, LLC | $119.77 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $118.99 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.99 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $118.99 | 2023 | Camzyos |
| Jazz Pharmaceuticals INC. | $118.99 | 2024 | |
| Sk Life Science, INC. | $101.96 | 2025 | Xcopri |
| Exact Sciences Corporation | $97.77 | 2025 | The Cologuard Plus Collection Kit |
| Ferring Pharmaceuticals INC. | $96.14 | 2023 | Rebyota |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $96.14 | 2025 | Vyvgart |
| Horizon Therapeutics Plc | $95.32 | 2022 | |
| Genzyme Corporation | $93.76 | 2025 | |
| Alexion Pharmaceuticals, INC. | $91.99 | 2024 | |
| Inspire Medical Systems, INC. | $91.06 | 2025 | Inspire |
| Biogen, INC. | $84.61 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.53 | 2023 | |
| Csl Behring | $62.12 | 2022-2023 | Kcentra |
| Amgen INC. | $60.51 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $60.34 | 2025 | Austedo Xr |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $54.40 | 2021 | |
| Kci USA, INC. | $38.39 | 2021-2023 | Prevena, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.